期刊文献+

骨转换生化标志物在原发性肾病综合征肾性骨营养不良诊断中的价值 被引量:1

Value of Biochemical Marker of Bone Turnover in Diagnosis of Renal Osteodystrophy in Patients with Primary Nephrotic Syndrome
下载PDF
导出
摘要 目的探讨骨转换生化标志物在原发性肾病综合征(PNS)肾性骨营养不良的早期诊断价值。方法检测30例PNS患者(PNS组)与50例健康体检者(对照组)血清中骨转换生化标志物总Ⅰ型前胶原氨基端延长肽(TPⅠNP)、Ⅰ型胶原羧基端肽β特殊序列(β-CTx)、完整甲状旁腺素(iPTH)及血清钙(Ca)、血清磷(P)、碱性磷酸酶(ALP)、25羟维生素D3[25-(OH)VD3]等相关生化指标之间的差异。结果 PNS组TPⅠNP、β-CTx、iPTH、ALP、Cr及Bun较对照组显著升高(P<0.01或P<0.05),Ca、25-(OH)VD3较对照组显著降低(均P<0.05);TPⅠNP与β-CTx、iPTH、ALP、Cr、Bun呈正相关(P<0.01或P<0.05),与Ca、25-(OH)VD3呈负相关(均P<0.01);β-CTx与iPTH、ALP、Cr、Bun呈正相关(P<0.01或P<0.05),与Ca、25-(OH)VD3呈负相关(均P<0.01)。结论联合检测TPⅠNP、β-CTx可提高对PNS患者并发肾性骨营养不良的早期诊断率。 ABSTRACT:Objective To explore the value of biochemical markers of bone turnover in early di-agnosis of renal osteodystrophy in patients with primary nephrotic syndrome(PNS).Methods The levels of total procollagen type Ⅰ amino-terminal propeptide of(TPⅠNP),β-isomerized car-boxyterminal propeptide(β-CTx),intact parathyroid hormone(iPTH),calcium(Ca),phosphorus (P),alkaline phosphatase(ALP),25-OH vitamin D3 ,creatinine(Cr)and blood urea nitrogen(Bun) in serum were measured in 30 PNS patients(PNS group)and 50 healthy subjects(control group). Results Compared with control group,levels of TPⅠ NP,β-CTx,iPTH,ALP,Cr and Bun in-creased,but levels of Ca and 25-OH vitamin D3 decreased in PNS group(P <0.01 or P <0.05). The levels of TPⅠNP were positively correlated with the levels of β-CTx,iPTH,ALP,Cr and Bun,but negatively correlated with the levels of Ca and 25-OH vitamin D3 (P < 0.01 or P <0.05).The levels ofβ-CTx were positively correlated with the levels of iPTH,ALP,Cr and Bun, but negatively correlated with Ca and 25-OH vitamin D3 (P < 0.01 or P < 0.05).Conclusion Combined detection of(TPⅠNP)andβ-CTx can improve the early diagnosis of renal osteodystro-phy in patients with PNS.
作者 方莉 范光磊
出处 《实用临床医学(江西)》 CAS 2015年第3期4-6,共3页 Practical Clinical Medicine
关键词 肾病综合征 肾性骨营养不良 骨转换生化标志物 nephrotic syndrome renal osteodystrophy bone turnover markers
  • 相关文献

参考文献1

二级参考文献13

  • 1Ortoft G,Andreassen TT,Oxlund H.Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats.Bone,2005,36:123-133. 被引量:1
  • 2Kim HJ.New understanding of glucocorticoid action in bone cells.BMB Rep,2010,43:524-529. 被引量:1
  • 3Weinstein RS,Chen JR,Powers CC,et al.Promoting of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.J Clin Invest,2002,109:1041-1048. 被引量:1
  • 4Angeli A,Guglielmi G,Dovio A,et al.High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy:a cross-sectional outpatient study.Bone,2006,39:253-259. 被引量:1
  • 5Pennisi P,Trombetti A,Rizzoli R.Glucocorticoid-induced osteoporosis and its treatment.Clin Orthop Relat Res,2006,443:39-47. 被引量:1
  • 6Van Staa TP,Cooper C,Leufkens HG,et al.Children and the risk of fractures caused by oral corticosteroids.J Bone Miner Res,2003,18:913-918. 被引量:1
  • 7Macrae VE,Ahmed SF,Mushtaq T,et al.IGF-1 signalling in bone growth:inhibitory actions of dexamethasone and IL1beta.Growth Horm IGF Res,2007,17:435-439. 被引量:1
  • 8Celiker R,Arslan S.Comparison of serum insulin-like growth factor-1 and growth hormone levels in osteoporotic and non-osteoporotic post-menopausal women.Rheumatol Int,2000,19:205-208. 被引量:1
  • 9Civitelli R,Ziambaras K.Epidemiology of glucocorticoidinduced osteoporosis.J Endocrinol Invest,2008,31:2-6. 被引量:1
  • 10Canalis E,Bilezikian JP,Angeli A,et al.Perspectives on glucocorticoid-induced osteoporosis.Bone,2004,34:593-598. 被引量:1

共引文献10

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部